Resources by service
The journey from production line to patient: exploring the end-to-end requirements of a successful cold chain operation
While the clinical trial landscape is ever evolving with an increase in biologic drugs being trialed, the need to supply patients with safe, compliant IMP remains unaffected. Running globalised trials involving temperature sensitive products magnifies the need for sponsors to develop effective risk mitigations that safeguard product integrity and promote patient safety.
One of the most high-risk areas of managing such trials is the clinical cold chain; where failure to consider potential packaging, labelling, and distribution challenges can compromise a trial’s timing, safety, and commercial viability.
Download our latest article that explores the cold chain journey, from production line to patient, to learn how you can overcome challenges within your temperature controlled supply chain.
*By submitting your information you acknowledge that you have read the privacy statement and you consent to our processing the data in accordance with that privacy statement. We may, from time to time, send you material relevant to your interests. If you change your mind at any time about wishing to receive material from us, you can send an email to firstname.lastname@example.org. Every email we send you will also include an unsubscribe link so you can unsubscribe from our marketing list.